133 related articles for article (PubMed ID: 28445138)
21. Roles of HLA-G/KIR2DL4 in Breast Cancer Immune Microenvironment.
Zheng G; Jia L; Yang AG
Front Immunol; 2022; 13():791975. PubMed ID: 35185887
[TBL] [Abstract][Full Text] [Related]
22. Establishment of a Langerhans cell histiocytosis lesion cell line with dermal dendritic cell characteristics.
Murakami I; Gogusev J; Jaubert F; Matsushita M; Hayashi K; Miura I; Tanaka T; Oka T; Yoshino T
Oncol Rep; 2015 Jan; 33(1):171-8. PubMed ID: 25351656
[TBL] [Abstract][Full Text] [Related]
23. Morphoproteomics provides support for TGF-β pathway signaling in the osteoclastogenesis and immune dysregulation of osteolytic Langerhans cell histiocytosis.
Alexandrescu S; Tatevian N; Czerniak BA; Covinsky MH; Burns NK; Brown RE
Int J Clin Exp Pathol; 2012; 5(6):503-11. PubMed ID: 22949932
[TBL] [Abstract][Full Text] [Related]
24. Tyrosine phosphatase SHP-1 is expressed higher in multisystem than in single-system Langerhans cell histiocytosis by immunohistochemistry.
Murakami I; Oka T; Kuwamoto S; Kato M; Hayashi K; Gogusev J; Imamura T; Morimoto A; Imashuku S; Yoshino T
Virchows Arch; 2011 Aug; 459(2):227-34. PubMed ID: 21604205
[TBL] [Abstract][Full Text] [Related]
25. Human leukocyte antigen-G, a ligand for the natural killer receptor KIR2DL4, is expressed by eutopic endometrium only in the menstrual phase.
Kawashima M; Maeda N; Adachi Y; Takeuchi T; Yamamoto Y; Izumiya C; Hayashi K; Furihata M; Udaka K; Fukaya T
Fertil Steril; 2009 Feb; 91(2):343-9. PubMed ID: 18314122
[TBL] [Abstract][Full Text] [Related]
26. Detection of IL-17A-producing peripheral blood monocytes in Langerhans cell histiocytosis patients.
Lourda M; Olsson-Åkefeldt S; Gavhed D; Björnfot S; Clausen N; Hjalmars U; Sabel M; Tazi A; Aricò M; Delprat C; Henter JI; Svensson M
Clin Immunol; 2014 Jul; 153(1):112-22. PubMed ID: 24743018
[TBL] [Abstract][Full Text] [Related]
27. Langerhans' cell histiocytosis: expression of leukocyte cellular adhesion molecules suggests abnormal homing and differentiation.
de Graaf JH; Tamminga RY; Kamps WA; Timens W
Am J Pathol; 1994 Mar; 144(3):466-72. PubMed ID: 7510455
[TBL] [Abstract][Full Text] [Related]
28. A novel fusion gene PLEKHA6-NTRK3 in langerhans cell histiocytosis.
Cai J; Huang X; Yin M; Pan C; Song L; Zhan Z; Chen J; Gao Y; Tang J; Li Y; Shen S
Int J Cancer; 2019 Jan; 144(1):117-124. PubMed ID: 30098202
[TBL] [Abstract][Full Text] [Related]
29. BRAFV600E mutation in cutaneous lesions of patients with adult Langerhans cell histiocytosis.
Varga E; Korom I; Polyánka H; Szabó K; Széll M; Baltás E; Bata-Csörgő Z; Kemény L; Oláh J
J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1205-11. PubMed ID: 25351766
[TBL] [Abstract][Full Text] [Related]
30. Activation of NK cells by an endocytosed receptor for soluble HLA-G.
Rajagopalan S; Bryceson YT; Kuppusamy SP; Geraghty DE; van der Meer A; Joosten I; Long EO
PLoS Biol; 2006 Jan; 4(1):e9. PubMed ID: 16366734
[TBL] [Abstract][Full Text] [Related]
31. Three common alleles of KIR2DL4 (CD158d) encode constitutively expressed, inducible and secreted receptors in NK cells.
Goodridge JP; Lathbury LJ; Steiner NK; Shulse CN; Pullikotil P; Seidah NG; Hurley CK; Christiansen FT; Witt CS
Eur J Immunol; 2007 Jan; 37(1):199-211. PubMed ID: 17171757
[TBL] [Abstract][Full Text] [Related]
32. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.
Allen CE; Li L; Peters TL; Leung HC; Yu A; Man TK; Gurusiddappa S; Phillips MT; Hicks MJ; Gaikwad A; Merad M; McClain KL
J Immunol; 2010 Apr; 184(8):4557-67. PubMed ID: 20220088
[TBL] [Abstract][Full Text] [Related]
33. Expression of cellular adhesion molecules in Langerhans cell histiocytosis and normal Langerhans cells.
de Graaf JH; Tamminga RY; Kamps WA; Timens W
Am J Pathol; 1995 Oct; 147(4):1161-71. PubMed ID: 7573361
[TBL] [Abstract][Full Text] [Related]
34. BRAFV600E and MAP2K1 mutations in Langerhans cell histiocytosis occur predominantly in children.
Zeng K; Ohshima K; Liu Y; Zhang W; Wang L; Fan L; Li M; Li X; Wang Z; Guo S; Yan Q; Guo Y
Hematol Oncol; 2017 Dec; 35(4):845-851. PubMed ID: 27597420
[TBL] [Abstract][Full Text] [Related]
35. Clonal status and clinicopathological features of Langerhans cell histiocytosis.
Gong L; Zhang WD; Li YH; Liu XY; Yao L; Han XJ; Zhu SJ; Lan M; Zhang W
J Int Med Res; 2010; 38(3):1099-105. PubMed ID: 20819448
[TBL] [Abstract][Full Text] [Related]
36. Histologic patterns of thymic involvement in Langerhans cell proliferations: a clinicopathologic study and review of the literature.
Picarsic J; Egeler RM; Chikwava K; Patterson K; Jaffe R
Pediatr Dev Pathol; 2015; 18(2):127-38. PubMed ID: 25629953
[TBL] [Abstract][Full Text] [Related]
37. Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells.
Hutter C; Kauer M; Simonitsch-Klupp I; Jug G; Schwentner R; Leitner J; Bock P; Steinberger P; Bauer W; Carlesso N; Minkov M; Gadner H; Stingl G; Kovar H; Kriehuber E
Blood; 2012 Dec; 120(26):5199-208. PubMed ID: 23074278
[TBL] [Abstract][Full Text] [Related]
38. DNA-PKcs controls an endosomal signaling pathway for a proinflammatory response by natural killer cells.
Rajagopalan S; Moyle MW; Joosten I; Long EO
Sci Signal; 2010 Feb; 3(110):ra14. PubMed ID: 20179272
[TBL] [Abstract][Full Text] [Related]
39. Lack of KIR2DL4 gene in a fertile Caucasian woman.
Nowak I; Majorczyk E; Płoski R; Senitzer D; Sun JY; Kuśnierczyk P
Tissue Antigens; 2011 Aug; 78(2):115-9. PubMed ID: 21623736
[TBL] [Abstract][Full Text] [Related]
40. [Langerhans cell histiocytosis: a clinicopathologic and immunohistochemical analysis of 258 cases].
Xu X; Liu WP; Yang QP; Wang WY; Liao DY; Zhao S; Bi CF; Lin L; Min M
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):91-6. PubMed ID: 22455884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
